Improving Hypertension Management Through Preference List Defaults
Part of paid clinical trials in Danville, Pennsylvania.
- Sponsor
- Geisinger Clinic
- Study ID
- NCT07298694
- Status
- Enrolling By Invitation
Conditions
- Choice Behavior
- Clinical Decision Support
- Hypertension
- Quality Improvement
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Revising preference list by adding "(PREFERRED)" to combination medication names — BEHAVIORALProviders in the intervention group will see "(PREFERRED)" listed before combination blood pressure medication names, which will frequently cause the combination medications to appear at the top of the EHR preference list.
Study Details
This study aims to evaluate whether modifying the EPIC preference list to display combination blood pressure (BP) medications at the top and/or adding "(PREFERRED)" to the beginning of the medication listing increases prescribing of these medications. Combination BP medications are aligned with value-based care guidelines and may improve patient adherence and reduce pill burden. Currently, these medications may be under-prescribed in part due to their low visibility in the EPIC prescribing interface.
Key Dates
- Start date
- Apr 13, 2026
- Status verified
- Apr 2026
- Primary completion
- Oct 31, 2026
- Completion
- Oct 31, 2026
Study Design
- Enrollment
- 12,150 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Revised Preference List"(PREFERRED)" will be added to the beginning of the preference list for selected BP medications, which will frequently cause these medications to be listed first.
- No Intervention: No Change to the Preference ListClinics will retain the usual EHR preference list order, with no changes to the default medication display.
Primary Outcome Measure
Prescribing of Combination Antihypertensive Medication (y/n) [ Time Frame: Day of the appointment (1 day) ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Geisinger | Danville | Pennsylvania | 17822 | - |
Find similar trials in Danville, PA
By condition
By specialty
By research site
Related Studies
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Phoenix, Arizona
- The Path to Optimal Black Maternal Heart Health: Comparing Two CVD Risk Reduction Interventions (Change of HEART)Recruiting · Temple University · Philadelphia, Pennsylvania
- BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenTRecruiting · Orchestra BioMed, Inc · Scottsdale, Arizona